TTM
15.1%
YoY change
+6.58pp
Trough year (1999)
-12.2%
Peak year (2009)
26.8%
Latest annual
20.0%
FCF Margin history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: 20.0%
FCF Margin change chart for AstraZeneca (AZN) from 1990 to 2025
Latest: +6.58pp
FCF Margin history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | 20.0% | +6.58pp | ||
| 2024 | 13.5% | -0.88pp | ||
| 2023 | 14.3% | -1.98pp | ||
| 2022 | 16.3% | +6.26pp | ||
| 2021 | 10.1% | +1.82pp | ||
| 2020 | 8.2% | +6.15pp | ||
| 2019 | 2.1% | -3.56pp | ||
| 2018 | 5.6% | -3.07pp | ||
| 2017 | 8.7% | +0.76pp | ||
| 2016 | 8.0% | +5.79pp | ||
| 2015 | 2.2% | -14.05pp | ||
| 2014 | 16.2% | -4.48pp | ||
| 2013 | 20.7% | +12.37pp | ||
| 2012 | 8.3% | -11.10pp | ||
| 2011 | 19.4% | -5.41pp | ||
| 2010 | 24.8% | -1.94pp | ||
| 2009 | 26.8% | +11.89pp | ||
| 2008 | 14.9% | -4.84pp | ||
| 2007 | 19.7% | -4.27pp | ||
| 2006 | 24.0% | -0.07pp | ||
| 2005 | 24.1% | +2.87pp | ||
| 2004 | 21.2% | +9.87pp | ||
| 2003 | 11.3% | -8.26pp | ||
| 2002 | 19.6% | +16.89pp | ||
| 2001 | 2.7% | -2.14pp | ||
| 2000 | 4.8% | +17.01pp | ||
| 1999 | -12.2% | -12.49pp | ||
| 1998 | 0.3% | +0.40pp | ||
| 1997 | -0.1% | -1.72pp | ||
| 1996 | 1.6% | -0.42pp | ||
| 1995 | 2.0% | +0.14pp | ||
| 1994 | 1.9% | -1.80pp | ||
| 1993 | 3.7% | +7.01pp | ||
| 1992 | -3.3% | -4.95pp | ||
| 1991 | 1.6% | -1.99pp | ||
| 1990 | 3.6% | — |
- 202520.0%+6.58pp
- 202413.5%-0.88pp
- 202314.3%-1.98pp
- 202216.3%+6.26pp
- 202110.1%+1.82pp
- 20208.2%+6.15pp
- 20192.1%-3.56pp
- 20185.6%-3.07pp
- 20178.7%+0.76pp
- 20168.0%+5.79pp
- 20152.2%-14.05pp
- 201416.2%-4.48pp
- 201320.7%+12.37pp
- 20128.3%-11.10pp
- 201119.4%-5.41pp
- 201024.8%-1.94pp
- 200926.8%+11.89pp
- 200814.9%-4.84pp
- 200719.7%-4.27pp
- 200624.0%-0.07pp
- 200524.1%+2.87pp
- 200421.2%+9.87pp
- 200311.3%-8.26pp
- 200219.6%+16.89pp
- 20012.7%-2.14pp
- 20004.8%+17.01pp
- 1999-12.2%-12.49pp
- 19980.3%+0.40pp
- 1997-0.1%-1.72pp
- 19961.6%-0.42pp
- 19952.0%+0.14pp
- 19941.9%-1.80pp
- 19933.7%+7.01pp
- 1992-3.3%-4.95pp
- 19911.6%-1.99pp
- 19903.6%—
FCF Margin values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported free cash flow margin is 15.1%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AstraZeneca (AZN) most recent annual free cash flow margin stands at 20.03% (2025) – expanded 6.6 percentage points year-over-year.
2009 marks the peak free cash flow margin at 26.77%, with the historical low of -12.18% recorded in 1999.
AstraZeneca FCF Margin by Year
AstraZeneca FCF Margin 2025: 20.0%
AstraZeneca free cash flow margin in 2025 was 20.03%, expanded 6.6 percentage points from 2024.
AstraZeneca FCF Margin 2024: 13.5%
2024's free cash flow margin for AstraZeneca came in at 13.45%, contracted 0.9 percentage points from 2023.
AstraZeneca FCF Margin 2023: 14.3%
AstraZeneca posted free cash flow margin of 14.33% in 2023, contracted 2.0 percentage points from 2022.
AstraZeneca FCF Margin 2022: 16.3%
In 2022, AstraZeneca reported free cash flow margin of 16.32%, expanded 6.3 percentage points from 2021.
AstraZeneca FCF Margin 2021: 10.1%
AstraZeneca free cash flow margin in 2021 was 10.06%.
See more financial history for AstraZeneca (AZN).
Sector peers by FCF Margin
Healthcare peers of AstraZeneca (AZN), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 14.9% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation